Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
September 30, 2026 133.24M
June 30, 2026 133.24M
March 31, 2026 113.24M
December 31, 2025 2.167M
September 30, 2025 1.642M
June 30, 2025 0.605M
March 31, 2025 16.03M
December 31, 2024 0.4291M
September 30, 2024 10.20M
June 30, 2024 8.553M
March 31, 2024 8.539M
December 31, 2023 8.401M
September 30, 2023 8.401M
June 30, 2023 8.401M
March 31, 2023 8.401M
December 31, 2022 8.401M
September 30, 2022 8.259M
June 30, 2022 8.259M
March 31, 2022 8.259M
December 31, 2021 8.259M
September 30, 2021 8.133M
June 30, 2021 0.0664M
March 31, 2021 0.0402M
December 31, 2020 0.0174M
September 30, 2020 0.0353M
Date Value
June 30, 2020 0.8678M
March 31, 2020 0.6622M
December 31, 2019 0.4487M
September 30, 2019 0.4377M
June 30, 2019 0.4163M
March 31, 2019 0.4162M
December 31, 2018 0.4154M
September 30, 2018 0.4153M
June 30, 2018 0.4153M
March 31, 2018 0.3259M
December 31, 2017 0.3259M
September 30, 2017 0.3259M
June 30, 2017 0.1717M
December 31, 2015 0.1431M
September 30, 2015 0.1329M
June 30, 2015 0.0701M
March 31, 2015 0.0675M
December 31, 2014 3.375M
September 30, 2014 2.888M
June 30, 2014 2.887M
March 31, 2014 2.855M
December 31, 2013 2.847M
September 30, 2013 2.838M
June 30, 2013 2.643M
March 31, 2013 2.642M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Cypherpunk Technologies, Inc. 144.10M
Capricor Therapeutics, Inc. 58.14M
Ocugen, Inc. 339.31M
Cue Biopharma, Inc. 7.754M
Yarrow Bioscience, Inc. 11.47M